Oct 26, 2026 08:01AM
Oct 26, 2026 08:01AM
Oct 19, 2026 08:06AM
Oct 19, 2026 08:01AM
Oct 14, 2026 08:01AM
Oct 14, 2026 08:01AM
May 12, 2025 04:30PM Hepion Pharmaceuticals (HEPA) Announces Receipt of Delisting Notification from Nasdaq
May 12, 2025 04:30PM
May 7, 2025 08:31AM
May 7, 2025 08:30AM
Mar 14, 2025 08:30AM
Mar 14, 2025 08:30AM
Jan 22, 2025 08:00AM
Jan 22, 2025 08:00AM Hepion Pharmaceuticals Announces $9.0 Million Public Offering
Dec 11, 2024 08:01AM
Dec 11, 2024 08:00AM
Dec 2, 2024 08:01AM
Dec 2, 2024 08:00AM
Jul 22, 2024 08:03AM
Jul 22, 2024 08:00AM
Apr 19, 2024 04:30PM Hepion Pharmaceuticals (HEPA) Winds Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
Apr 19, 2024 04:30PM
Mar 6, 2024 08:30AM
Mar 6, 2024 08:30AM
Feb 16, 2024 08:02AM
Feb 16, 2024 08:00AM
Jan 3, 2024 05:15PM
Dec 7, 2023 08:01AM Hepion Pharmaceuticals (HEPA) Announces Restructuring Plan to Enhance Shareholder Value and Management Changes
Dec 7, 2023 08:00AM
Nov 28, 2023 04:15PM
Nov 28, 2023 04:15PM
Nov 13, 2023 04:06PM
Nov 13, 2023 04:05PM
Nov 13, 2023 04:05PM
Nov 10, 2023 08:50AM Hepion Pharmaceuticals Schedules Conference Call to Review Additional Efficacy Data from Phase 2 ‘ALTITUDE-NASH’ Liver Function Trial of Rencofilstat
Oct 25, 2023 08:30AM
Oct 25, 2023 08:30AM
Sep 29, 2023 08:02AM
Sep 29, 2023 08:00AM
Sep 21, 2023 04:05PM
Sep 21, 2023 08:00AM
Sep 19, 2023 09:00AM Hepion Pharmaceuticals Discovers Novel Rencofilstat Action in Liver Cancer
Sep 14, 2023 08:45AM
Sep 6, 2023 04:30PM
Jun 15, 2023 04:45PM
Jun 15, 2023 08:22AM
Jun 15, 2023 08:22AM
May 24, 2023 04:45PM
May 22, 2023 07:00AM Hepion Pharmaceuticals' (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints
May 22, 2023 07:00AM

335,394 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All